GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (NYSE:DVA) » Definitions » Cyclically Adjusted PB Ratio

DaVita (DaVita) Cyclically Adjusted PB Ratio : 5.93 (As of Apr. 27, 2024)


View and export this data going back to 1995. Start your Free Trial

What is DaVita Cyclically Adjusted PB Ratio?

As of today (2024-04-27), DaVita's current share price is $133.51. DaVita's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $22.50. DaVita's Cyclically Adjusted PB Ratio for today is 5.93.

The historical rank and industry rank for DaVita's Cyclically Adjusted PB Ratio or its related term are showing as below:

DVA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.13   Med: 4.35   Max: 7.9
Current: 5.9

During the past years, DaVita's highest Cyclically Adjusted PB Ratio was 7.90. The lowest was 2.13. And the median was 4.35.

DVA's Cyclically Adjusted PB Ratio is ranked worse than
81.85% of 303 companies
in the Healthcare Providers & Services industry
Industry Median: 1.94 vs DVA: 5.90

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

DaVita's adjusted book value per share data for the three months ended in Dec. 2023 was $11.890. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $22.50 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


DaVita Cyclically Adjusted PB Ratio Historical Data

The historical data trend for DaVita's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Cyclically Adjusted PB Ratio Chart

DaVita Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.54 5.46 5.00 3.22 4.66

DaVita Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.22 3.50 4.35 4.12 4.66

Competitive Comparison of DaVita's Cyclically Adjusted PB Ratio

For the Medical Care Facilities subindustry, DaVita's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita's Cyclically Adjusted PB Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where DaVita's Cyclically Adjusted PB Ratio falls into.



DaVita Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

DaVita's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=133.51/22.5
=5.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, DaVita's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=11.89/129.4194*129.4194
=11.890

Current CPI (Dec. 2023) = 129.4194.

DaVita Quarterly Data

Book Value per Share CPI Adj_Book
201403 21.769 99.695 28.260
201406 22.284 100.560 28.679
201409 23.153 100.428 29.837
201412 23.977 99.070 31.322
201503 23.116 99.621 30.030
201506 23.887 100.684 30.704
201509 23.650 100.392 30.488
201512 23.221 99.792 30.115
201603 22.791 100.470 29.358
201606 22.938 101.688 29.193
201609 24.464 101.861 31.083
201612 23.891 101.863 30.354
201703 26.413 102.862 33.232
201706 26.592 103.349 33.300
201709 25.284 104.136 31.423
201712 25.704 104.011 31.983
201803 25.667 105.290 31.549
201806 25.051 106.317 30.495
201809 23.042 106.507 27.999
201812 22.258 105.998 27.176
201903 23.290 107.251 28.104
201906 24.620 108.070 29.484
201909 17.317 108.329 20.688
201912 16.953 108.420 20.237
202003 15.992 108.902 19.005
202006 17.657 108.767 21.010
202009 13.840 109.815 16.311
202012 12.586 109.897 14.822
202103 11.344 111.754 13.137
202106 12.097 114.631 13.658
202109 11.145 115.734 12.463
202112 7.766 117.630 8.544
202203 8.860 121.301 9.453
202206 6.559 125.017 6.790
202209 5.912 125.227 6.110
202212 7.879 125.222 8.143
202303 9.106 127.348 9.254
202306 11.148 128.729 11.208
202309 13.128 129.860 13.084
202312 11.890 129.419 11.890

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


DaVita  (NYSE:DVA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


DaVita Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of DaVita's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


DaVita (DaVita) Business Description

Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Executives
Christopher Michael Berry officer: Chief Accounting Officer C/O SONDER HOLDINGS INC., 101 15TH ST., SAN FRANCISCO CA 94103
Kathleen Alyce Waters officer: Chief Legal Officer C/O DAVITA INC., 2000 16TH STREET, DENVER CO 80202
Wendy Lee Schoppert director 6105 TRENTON LANE NORTH, MINNEAPOLIS MN 55442
Phyllis R Yale director
Javier Rodriguez officer: Chief Executive Officer, DKC 601 HAWAII ST., EL SEGUNDO CA 90245
Barbara J Desoer director CITIGROUP INC., 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10013
James O Hearty officer: Chief Compliance Officer 2000 16TH STREET, DENVER CO 80202
Charles Berg director, officer: Executive Chair, DMG 48 MONROE TURNPIKE, TRUMBULL CT 06611
John M Nehra director 1119 ST PAUL ST, BALTIMORE MD 21202
Adam H Schechter director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Michael David Staffieri officer: Chief Operating Officer, DKC 2000 16TH STREET, DENVER CO 80202
Jason M. Hollar director 3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179
Paula A Price director ONE CVS DRIVE, WOONSOCKET RI 02895
Pamela M Arway director 601 HAWAII ST., EL SEGUNDO CA 90245
Gregory J. Moore director 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601

DaVita (DaVita) Headlines